In this report, the United States In-Vitro Fertilization (IVF) Devices Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
In-Vitro Fertilization (IVF) is an advanced medical procedure that involves the combination of surgical procedures and medicines to help in the implantation of eggs in the uterus. This procedure is basically performed on the women that cannot have a normal pregnancy. In this procedure eggs are infused with sperm outside the uterus in an artificial environment - this procedure is also called insemination where sperms and eggs are stored in a special container to promote the fertilization of eggs. After a few days, the fertilized egg is implanted into the womb of women which is called embryo transfer.
Growing cases of infertility cases in the U.S. country is primarily fueling the market growth of In-Vitro Fertilization (IVF) devices. According to the Centers for Disease Control and Prevention (CDC), about 10 percent of women (6.1 million) in the United States ages 15-44 have difficulty getting pregnant or staying pregnant. Moreover, the growing focus of manufacturers to introduce advanced in-vitro fertilization devices is further anticipated to foster market growth. For instance, in July 2018, Merck, a leading science and technology company, announced the launch of QBOX IVF, and the new Geri® Assess 2.0, in its continued drive to serve the needs of its customers and to become the preferred treatment partner for all IVF stakeholders and assisted reproductive treatment (ART) clinics.
Key Developments:
- In January 2019, Ferring Pharmaceuticals has agreed on terms to acquire the US commercialization rights for a generic version of ganirelix acetate, an injectable therapy used to prevent premature luteinizing hormone surges in women undergoing fertility treatment.
- In November 2016, Merck has introduced two fertility technologies, Gidget and Geri+ to extend its portfolio to support all steps performed by fertility laboratories during assisted reproductive treatment.
- In April 2018, the Cooper Companies, Inc., announced that CooperSurgical has acquired the assets of The LifeGlobal Group and its affiliates, a provider of in-vitro fertilization (IVF) devices. The transaction is valued at approximately $125 million and is expected to be neutral to earnings per share in fiscal 2018 and accretive thereafter, excluding one-time charges and deal-related amortization.
- In October 2016, Merck KGaA’s North American unit established a Fertility Technologies division with the launch of its hand-held witnessing device for the facilitation of in vitro fertilization procedures. EMD Serono is the German company’s biopharmaceutical business in the U.S. and Canada.
- In March 2019, INVO Bioscience, Inc, developers of the INVOcell intravaginal culture (IVC) system, today announced the launch of its first Company-owned embryology center in the Bay Area of California.
Geographically, this report splits the United States market into seven regions:
✒ The West
✒ Southwest
✒ The Middle Atlantic
✒ New England
✒ The South
✒ The Midwest
with sales (volume), revenue (value), market share and growth rate of In-Vitro Fertilization (IVF) Devices in these regions, from 2014 to 2025 (forecast).
United States In-Vitro Fertilization (IVF) Devices market competition by top manufacturers/players, with In-Vitro Fertilization (IVF) Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
✒ Esco
✒ Memmert
✒ Hamilton
✒ Vitrolife
✒ EurimPharm
✒ SunIVF
✒ Origio Humagen
✒ COOK
✒ Nidacon
✒ Meditex
✒ Nuode Medical
✒ Hema
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
✒ Intracytoplasmic Sperm Injection (ICSI)
✒ Frozen Embryo Replacement (FER)
✒ Pre-implantation Genetic Diagnosis (PGD)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of In-Vitro Fertilization (IVF) Devices for each application, including
✒ Clone
✒ Transgenic
✒ Embryonic Stem Cell Isolation and Culture
✒ Test Tube Baby
**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States In-Vitro Fertilization (IVF) Devices Market Report 2019
1 In-Vitro Fertilization (IVF) Devices Overview
1.1 Product Overview and Scope of In-Vitro Fertilization (IVF) Devices
1.2 Classification of In-Vitro Fertilization (IVF) Devices by Product Category
1.2.1 United States In-Vitro Fertilization (IVF) Devices Market Size (Sales Volume) Comparison by Type (2014-2025)
1.2.2 United States In-Vitro Fertilization (IVF) Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2018
1.2.3 Intracytoplasmic Sperm Injection (ICSI)
1.2.4 Frozen Embryo Replacement (FER)
1.2.5 Pre-implantation Genetic Diagnosis (PGD)
1.3 United States In-Vitro Fertilization (IVF) Devices Market by Application/End Users
1.3.1 United States In-Vitro Fertilization (IVF) Devices Market Size (Consumption) and Market Share Comparison by Application (2014-2025)
1.3.2 Clone
1.3.3 Transgenic
1.3.4 Embryonic Stem Cell Isolation and Culture
1.3.5 Test Tube Baby
1.4 United States In-Vitro Fertilization (IVF) Devices Market by Region
1.4.1 United States In-Vitro Fertilization (IVF) Devices Market Size (Value) Comparison by Region (2014-2025)
1.4.2 The West In-Vitro Fertilization (IVF) Devices Status and Prospect (2014-2025)
1.4.3 Southwest In-Vitro Fertilization (IVF) Devices Status and Prospect (2014-2025)
1.4.4 The Middle Atlantic In-Vitro Fertilization (IVF) Devices Status and Prospect (2014-2025)
1.4.5 New England In-Vitro Fertilization (IVF) Devices Status and Prospect (2014-2025)
1.4.6 The South In-Vitro Fertilization (IVF) Devices Status and Prospect (2014-2025)
1.4.7 The Midwest In-Vitro Fertilization (IVF) Devices Status and Prospect (2014-2025)
1.5 United States Market Size (Value and Volume) of In-Vitro Fertilization (IVF) Devices (2014-2025)
1.5.1 United States In-Vitro Fertilization (IVF) Devices Sales and Growth Rate (2014-2025)
1.5.2 United States In-Vitro Fertilization (IVF) Devices Revenue and Growth Rate (2014-2025)
2 United States In-Vitro Fertilization (IVF) Devices Market Competition by Players/Suppliers
2.1 United States In-Vitro Fertilization (IVF) Devices Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States In-Vitro Fertilization (IVF) Devices Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States In-Vitro Fertilization (IVF) Devices Average Price by Players/Suppliers (2014-2019)
2.4 United States In-Vitro Fertilization (IVF) Devices Market Competitive Situation and Trends
2.4.1 United States In-Vitro Fertilization (IVF) Devices Market Concentration Rate
2.4.2 United States In-Vitro Fertilization (IVF) Devices Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers In-Vitro Fertilization (IVF) Devices Manufacturing Base Distribution, Sales Area, Product Type
3 United States In-Vitro Fertilization (IVF) Devices Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States In-Vitro Fertilization (IVF) Devices Sales and Market Share by Region (2014-2019)
3.2 United States In-Vitro Fertilization (IVF) Devices Revenue and Market Share by Region (2014-2019)
3.3 United States In-Vitro Fertilization (IVF) Devices Price by Region (2014-2019)
4 United States In-Vitro Fertilization (IVF) Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States In-Vitro Fertilization (IVF) Devices Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States In-Vitro Fertilization (IVF) Devices Revenue and Market Share by Type (2014-2019)
4.3 United States In-Vitro Fertilization (IVF) Devices Price by Type (2014-2019)
4.4 United States In-Vitro Fertilization (IVF) Devices Sales Growth Rate by Type (2014-2019)
5 United States In-Vitro Fertilization (IVF) Devices Sales (Volume) by Application (2014-2019)
5.1 United States In-Vitro Fertilization (IVF) Devices Sales and Market Share by Application (2014-2019)
5.2 United States In-Vitro Fertilization (IVF) Devices Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States In-Vitro Fertilization (IVF) Devices Players/Suppliers Profiles and Sales Data
6.1 Esco
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Esco In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Memmert
6.2.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Memmert In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Hamilton
6.3.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Hamilton In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Vitrolife
6.4.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Vitrolife In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 EurimPharm
6.5.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 EurimPharm In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 SunIVF
6.6.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 SunIVF In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Origio Humagen
6.7.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Origio Humagen In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 COOK
6.8.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 COOK In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Nidacon
6.9.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Nidacon In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Meditex
6.10.2 In-Vitro Fertilization (IVF) Devices Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Meditex In-Vitro Fertilization (IVF) Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 Nuode Medical
6.12 Hema
7 In-Vitro Fertilization (IVF) Devices Manufacturing Cost Analysis
7.1 In-Vitro Fertilization (IVF) Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of In-Vitro Fertilization (IVF) Devices
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 In-Vitro Fertilization (IVF) Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of In-Vitro Fertilization (IVF) Devices Major Manufacturers in 2018
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States In-Vitro Fertilization (IVF) Devices Market Size (Value and Volume) Forecast (2019-2025)
11.1 United States In-Vitro Fertilization (IVF) Devices Sales Volume, Revenue Forecast (2019-2025)
11.2 United States In-Vitro Fertilization (IVF) Devices Sales Volume Forecast by Type (2019-2025)
11.3 United States In-Vitro Fertilization (IVF) Devices Sales Volume Forecast by Application (2019-2025)
11.4 United States In-Vitro Fertilization (IVF) Devices Sales Volume Forecast by Region (2019-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Request Discount 
Inquire Before Buy
